J Physiol Sign Up for eTOC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Physiol Volume 584, Number 2, 583-590, October 15, 2007 DOI: 10.1113/jphysiol.2007.140830
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
584/2/583    most recent
jphysiol.2007.140830v1
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lund, D. D.
Right arrow Articles by Heistad, D. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lund, D. D.
Right arrow Articles by Heistad, D. D.
Related Collections
Right arrow Cardiovascular

CARDIOVASCULAR

Effects of a common human gene variant of extracellular superoxide dismutase on endothelial function after endotoxin in mice

Donald D. Lund1,3, Yi Chu1, Robert M. Brooks1, Frank M. Faraci1,2 and Donald D. Heistad1,2,3

Departments of Internal Medicine
1 and Pharmacology
2 , Cardiovascular Center, University of Iowa Carver College of Medicine, and Veterans Affairs Medical Center
3 , Iowa City, Iowa 52242, USA

A common gene variant in the heparin-binding domain (HBD) of extracellular superoxide dismutase (ECSOD) may predispose human carriers to ischaemic heart disease. We have demonstrated that the HBD of ECSOD is important for ECSOD to restore vascular dysfunction produced by endotoxin. The purpose of this study was to determine whether the gene variant in the HBD of ECSOD (ECSODR213G) protects against endothelial dysfunction in a model of inflammation. We constructed a recombinant adenovirus that expresses ECSODR213G. Adenoviral vectors expressing ECSOD, ECSODR213G or beta-galactosidase (LacZ, a control) were injected I.V. in mice. After 3 days, at which time the plasma SOD activity is maximal, vehicle or endotoxin (lipopolysaccharide or LPS, 40 mg kg–1) was injected I.P. Vasomotor function of aorta in vitro was examined 1 day later. Maximal relaxation to sodium nitroprusside was similar in aorta from normal and LPS-treated mice. Maximal relaxation to acetylcholine (10–5) was impaired after LPS and LacZ (63 ± 3%, mean ± S.E.M.) compared to normal vessels (83 ± 3%) (P < 0.05). Gene transfer of ECSOD improved (P < 0.05) relaxation in response to acetylcholine (76 ± 5%) after LPS, whereas gene transfer of ECSODR213G had no effect (65 ± 4%). Superoxide was increased in aorta (measured using lucigenin and hydroethidine) after LPS, and levels of superoxide were significantly reduced following ECSOD but not ECSODR213G. Thus, ECSOD reduces superoxide and improves relaxation to acetylcholine in the aorta after LPS, while the ECSOD variant R213G had minimal effect. These findings suggest that, in contrast to ECSOD, the common human gene variant of ECSOD fails to protect against endothelial dysfunction produced by an inflammatory stimulus.

(Received 16 July 2007; accepted after revision 13 August 2007; first published online 23 August 2007)
Corresponding author: D. Heistad: 200 Hawkins Drive, Iowa City, IA 52242, USA. Email: donald-heistad{at}uiowa.edu







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 The Physiological Society.